October 16th 2023
Patients aged 12 years and up with completely resected Stage IIB/C melanoma can now be treated (adjuvant) with FDA-approved nivolumab (Opdivo; Bristol Meyers Squibb Company).
September 9th 2021
Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic
View More
Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients
View More
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Navigating a New Era of Food Allergy Management
Register Now!
ACCC 50th Annual Meeting & Cancer Center Business Summit (AMCCBS): Clinical Updates from San Diego on Hematologic Malignancies
Register Now!
Clinical Vignettes: Inaugural International Congress on Pediatric Oncology
View More
FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates
View More
Medical Crossfire®: Onco-Nursing Best Practices for Managing AEs Related to CAR T-Cell Therapy from Treatment Center to Community
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: How Has the Nurse’s Role Evolved in the Management of Pediatric Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas?
View More
2nd Annual International Congress on Pediatric Oncology
View More
Why do so many kids die so soon following a cancer diagnosis?
June 14th 2017While improvements have been made to childhood cancer mortality rates, a recent research study aims to identify how many children die before being able to start treatment, and what interventions can be put in place to improve their chances.
Breast, colon cancer rare but aggressive in kids
November 13th 2014Breast and colorectal cancers, although rare in children, are also more aggressive than in adults, according to 2 studies based on patient records from the National Cancer Data Base that were presented at the recent Clinical Congress of the American College of Surgeons.
CT scans increase risk of pediatric cancers
June 21st 2012In children younger than 15 years, 2 to 3 computed tomography (CT) scans of the head might triple the risk of brain tumors; 5 to 10 of them might triple the risk of leukemia. New research tries to answer the ongoing question of whether radiation from diagnostic scans causes these pediatric cancers.
Cell phones do not put young people at greater risk of brain cancer, study says
August 4th 2011Perennial concerns about whether cell phones cause brain cancer often focus on children and adolescents. In the first-of-its-kind study, Swiss researchers found that answer is no, and they also offer some advice to parents who are anxious.
Childhood cancer survivors at increased risk for GI complications
June 3rd 2011Health care providers should be aware that survivors of childhood cancer have an increased risk of developing gastrointestinal (GI) complications later in life and provide appropriate follow-up care, a study published in Gastroenterology indicates.
FDA approves Gardasil for prevention of anal cancer
December 29th 2010The US Food and Drug Administration (FDA) has approved use of the vaccine Gardasil in the population ages 9 through 26 years for the prevention of anal cancer and anal intraepithelial neoplasia (AIN) precancerous lesions grades 1, 2, and 3 caused by human papillomavirus (HPV) types 6, 11, 16, and 18.